Filled by a licensed US pharmacy we chose. See which one
Tirzepatide + B12, weekly injection
A once-weekly GLP-1 that works on two hormones, GLP-1 and GIP. Prescribed by a Seattle provider and filled by a licensed US pharmacy we chose.
With the 3-month plan. $219 month to month.
Already on tirzepatide? Our providers can match the dose you're on if it's right for you. How switching works
You only pay if a provider prescribes.
Injection supplies come with every order.
Every prescription gives 50 meals a month to those in need.
Tirzepatide is a once-weekly injection that acts on two hormones your gut releases after you eat.
Tells your brain you've eaten and slows how fast your stomach empties, so you feel full sooner and stay full longer.
Works alongside GLP-1 on appetite and on how your body releases insulin after a meal.
Semaglutide works on GLP-1 alone. Tirzepatide works on both. Compare with semaglutide
Tirzepatide is taken once a week. Doses run from 2.5 mg to 15 mg, in steps of 2.5 mg. Where you start and where you settle is a decision you make with your provider.
Weekly doses
New to tirzepatide, most people start at 2.5 mg, the dose meant to get your body used to the medication. Already taking it, your provider can continue you at the dose you're on now if it's right for you. How switching works
Changes usually come at least four weeks apart. Your provider looks at how you're feeling, any side effects, and how things are going toward your goals before suggesting a step.
Plenty of people stay on a dose that's working rather than climbing to the top. If side effects are hard to manage, you can ask to hold a dose longer or step back down.
Message your provider in your patient portal, or book a video visit at no extra cost.
Dose range as described in the FDA prescribing information for Zepbound (tirzepatide). Your provider's directions and your pharmacy label come first.
Many online GLP-1 platforms don't say which pharmacy makes their medication.
BrightSide offers high-quality treatment from pharmacies we grade and choose, prescribed by providers in Seattle.
"Consumers who purchase compounded drugs online, such as through online pharmacies and telehealth platforms, may not know the identity of the compounder that produced the drug"
U.S. Food and Drug Administration
BrightSideYou don't have to start over at 2.5 mg. If you're on a maintenance dose now, our providers can match it if it's right for you, so you pick up where you left off.
An example. Your provider reviews your history and current dose before prescribing.
Semaglutide and tirzepatide doses don't convert one to one. Your provider works out your tirzepatide starting dose with you.
After a longer break, your provider may suggest restarting a step or two lower and building back up.
The medication, your dose and when you took your last one.
They can match the dose you're on if it's right for you.
A licensed US pharmacy we chose fills your prescription and ships it to your door.
You only pay if a provider prescribes.
Tirzepatide has been tested in large clinical trials as the brand-name drug Zepbound. Compounded tirzepatide was not the drug studied in these trials.
Average weight loss after 72 weeks in 751 adults with obesity, each on the highest dose they could tolerate.
SURMOUNT-5. Aronne et al., New England Journal of Medicine, 2025.Average weight loss after 72 weeks in 2,539 adults with obesity or overweight, without diabetes.
SURMOUNT-1. Jastreboff et al., New England Journal of Medicine, 2022.People in both trials also followed a reduced-calorie diet and increased their physical activity. Results from Zepbound trials do not predict results with compounded tirzepatide, which is not FDA approved. Individual results vary.
State attorneys general and reporters have both reported altered and AI-generated before-and-after photos in weight-loss advertising.
In December 2025, 35 state attorneys general wrote to Meta about weight-loss ads. Their announcement said:
"Often, these ads use unlabeled AI-generated content including fake before and after images and nonexistent spokespeople."
On a GLP-1 telehealth company's first website, The New York Times reported:
"before-and-after weight-loss photos from around the web with the faces changed"
The results on this page are clinical trial averages for Zepbound, each linked to its source.
The only people pictured are Dr. Shannon Arora and Dr. Sean Arora.
The first month is about getting used to the medication. Here's what happens, in order.
Your pharmacy ships your vial with injection supplies. Put it in the refrigerator when it arrives and follow the storage directions on the label.
Pick a day of the week you can stick with. The injection goes just under the skin of your stomach or thigh, or the back of your upper arm if someone else gives it. Switch spots each week.
New to tirzepatide, your first month is usually at 2.5 mg. Switching from another provider, you may continue at the dose you're on now.
Nausea, diarrhea, constipation and an upset stomach are the most common side effects, and they tend to show up when you start and after a dose increase.
Smaller meals, stopping when you feel full, less greasy food and more water all help. If side effects don't settle, message your provider in your patient portal.
Your provider reviews how the first month went and decides with you whether to stay at your dose or move up to the next step.
Take it within four days. If it's been longer, skip it and take your next dose on your usual day.
Tirzepatide can make them less effective. Use a backup or non-pill method for four weeks after you start and for four weeks after each dose increase.
For severe stomach pain that won't go away, or signs of an allergic reaction like swelling of your face, lips or throat.
Dosing and side effect details from the FDA prescribing information for Zepbound (tirzepatide). Your provider's directions and your pharmacy label come first.
We grade the pharmacies we work with in five categories. More than eighty compounding pharmacies have been through our grading so far.
A physician-led medical group. A licensed provider reviews every visit and every dose change.
The same providers, after you start
A licensed provider from Arora Health in Seattle reviews every visit and every dose change. Questions about your dose, side effects or what comes next go to them in your patient portal.
No. Zepbound and Mounjaro are FDA-approved drugs made by Eli Lilly. Compounded tirzepatide is made by a state-licensed pharmacy for one patient, from a prescription. It is not FDA approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.
Semaglutide acts on one hormone, GLP-1. Tirzepatide acts on two, GLP-1 and GIP. In a head-to-head trial of the brand-name drugs, adults on Zepbound lost more weight on average than adults on Wegovy. Compounded tirzepatide was not the drug studied. Your provider can help you decide which fits you.
Not necessarily. Tell us what you take now and your current dose. A licensed provider reviews it and can match the dose you're on if it's right for you.
Yes. Semaglutide and tirzepatide doses don't convert one to one, so your provider works out your tirzepatide starting dose with you.
Both are weekly compounded tirzepatide. One vial is made with vitamin B12 and the other with glycine, an amino acid. You choose the version with your provider during your visit. See tirzepatide + glycine
A licensed US pharmacy we chose. Our pharmacy network page names each pharmacy that fills orders today and its licenses.
Cold. Your pharmacy packs your medication to stay at the right temperature on the way to your door. Put it in the refrigerator when it arrives. If anything about your delivery looks off, email hello@jointhebrightside.com before you use it.
No. Insurance isn't needed, and your visit, online or on video, is included in the treatment price.
You're not charged. Your card is only charged if a licensed provider prescribes your treatment.
With the 3-month plan. $219 month to month.
You only pay if a provider prescribes.
Tirzepatide may cause thyroid tumors. In studies in rats, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors in people. Do not use tirzepatide if you or a family member has ever had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Other serious side effects can include inflammation of the pancreas, gallbladder problems, low blood sugar, kidney problems, serious allergic reactions and, in people with type 2 diabetes, changes in vision. Tell your provider about every medication you take, and if you are pregnant, breastfeeding or planning to become pregnant. Tell your provider before any surgery or procedure that uses anesthesia or sedation.
Based on the FDA prescribing information for Zepbound (tirzepatide). Compounded tirzepatide is not FDA approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.
